Sheikh Shakhbout Medical City Unveils New Neuroscience Institute To Enhance Neurological Care In The UAE
Sheikh Shakhbout Medical City (SSMC), a major healthcare provider in the UAE, has introduced its Neuroscience Institute. This new facility is dedicated to delivering top-tier care for neurological issues, utilising cutting-edge technology and innovative treatments. The institute aims to serve patients of all ages, offering comprehensive services that were previously only accessible abroad.
The Neuroscience Institute at SSMC is structured to enhance the diagnosis, treatment, and research of neurological conditions. It encompasses various divisions such as adult neurology, paediatric neurology, neurosurgery, and interventional neuroradiology. The goal is to integrate advanced diagnostic and therapeutic technologies with pioneering research to improve patient outcomes.

Dr. Marwan Al Kaabi, CEO of SSMC, remarked on the institute's launch: "As part of our ongoing commitment to bringing life-changing advancements and elevating the standard of care through breakthrough innovations, our Neuroscience Institute will serve as a centre of comprehensive neurological care for patients in the UAE and beyond."
The institute is committed to a patient-focused approach across all operations. This aligns with SSMC's mission to provide compassionate care through integrated services. By prioritising patient education, the institute aims to promote early diagnosis and prevention of neurological disorders in both adults and children.
Dr. Abdulqader Almessabi, acting chief medical officer at SSMC, highlighted: "A key strength of the Neuroscience Institute is its comprehensive care approach, which facilitates coordinated care pathways for all patients." The institute boasts a team of skilled neurologists and neurosurgeons dedicated to offering a wide range of specialised services.
Collaborations and Innovations
The future vision for the Neuroscience Institute includes forming partnerships with academic institutions to boost research and training initiatives. Collaborations with industry leaders are also planned to incorporate the latest medical technologies into neurology treatments. These efforts aim to address unmet patient needs on a global scale.
The institute’s comprehensive care model ensures coordinated pathways from diagnosis through rehabilitation. This approach leverages groundbreaking technologies and novel treatments to improve patients' quality of life regardless of their age or condition.
By engaging with the community actively, SSMC intends to raise awareness about neurological conditions. Empowering patients with knowledge through education programmes will enable them to explore advanced care options effectively.
With inputs from WAM